Search results
Stocks of local interest
Clinton Herald, Iowa· 1 day agoJun. 21—Closing prices Friday: Adv Auto Parts 65.76 Abbott Labs 105.72 ADM 61.35 Ameriprise 440.88 AutoZone, Inc. 2,990.73 Boeing 176.56 Bank of America 39.49 BP PLC ADR 35.51 ConAgra Foods ...
Skip Meme Mania: 3 Undervalued Blue-Chip Stocks for Steady Returns
InvestorPlace· 3 days agoOn the other hand, investing in penny and meme stocks is exciting and attracts investors. Of course,...
Here's Why Eli Lilly (LLY) is Probably the Best Drug Stock Now
Zacks· 3 days agoOf these, at present, Eli Lilly appears to be a great stock to have in one’s portfolio based on its strong overall financial performance and robust drug pipeline. Lilly, with ...
Gateway - Quartz
Quartz· 5 days agoModerna stock rose after new data suggested that its experimental vaccine could be used to treat a variety of cancers. The American Society of Health-System Pharmacists said ...
3 Underrated Dividend Stock Machines to Turbocharge Your Income
InvestorPlace· 3 days agoOne of them is dividend stocks but you do not want to bet your money on companies that have...
Why Wall Street Is Chasing Ozempic Wannabes
The Wall Street Journal· 3 days agoAs Jared Holz, a healthcare equity strategist at ...troubles. Companies such as Bristol-Myers Squibb Pfizer Johnson & Johnson and Merck are all facing...
Sarepta Stock Surges on Expanded Elevidys Approval. It’s a ‘Best-Case’ Scenario for Shares.
Barrons.com· 2 days agoThe biopharmaceutical company says the drug was approved for ambulatory and non-ambulatory people,...
Gilead (GILD) Up as Twice-Yearly HIV Shot Prevents Infection
Zacks via Yahoo Finance· 2 days agoGilead's (GILD) twice-yearly, subcutaneous lenacapavir has demonstrated its potential as a new tool...
Novavax (NVAX) Seeks FDA Nod for Updated COVID-19 Vaccine
Zacks via Yahoo Finance· 6 days agoNovavax (NVAX) seeks FDA???s approval to update its COVID-19 vaccine for the 2024-2025 fall season...
FDA Expands Sarepta's (SRPT) DMD Gene Therapy Label
Zacks via Yahoo Finance· 2 days agoFollowing the label expansion, Sarepta's (SRPT) Elevidys is approved to treat all DMD patients aged four years and older, regardless of ambulation...
